Topics

Articles

How the development of more quantitative and qualitative data around the patient can drive better-informed care decisions—and help avoid potential overstock scenarios that can deplete earnings 

Effective patient-first approach in rare disease relies on true sales—not channel stocking 

How pharma’s retooling of its promotional efforts in the post-pandemic era impacts sizing and targeting, two crucial foundational pieces to successful commercialization

Maximizing HCP engagement as the definition of a sales ‘call’ expands

Arthrex to receive US rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sports medicine

Celularity and Arthrex ink exclusive commercial supply and distribution pact 

Michael Christel is Group Managing Editor of Pharmaceutical Commerce, Pharmaceutical Executive, and Applied Clinical Trials. He can be reached at mchristel@mjhlifesciences.com.

A conversation with Vin Colicchio, vice president, supply chain and external manufacturing, Dr. Reddy’s Laboratories 

People, production, and priorities

A well-oiled, data-driven hub program is critical for stakeholders in supporting patients—and clearing a successful path for specialty therapies

Today's hub blueprint: Lock in on the journey

A conversation with Cathy Traz, global advocacy head at Bristol Myers Squibb

Keeping the message moving during Covid

Covid-19 reveals how important field reps will be to driving digital adoption

Digital is reinventing the critical role of the rep

Embracing AI 2.0 and modern machine learning as foundational tools to deepening HCP engagement

Next-gen AI: Widespread adoption hinges on trust

Using technology to enable processes, drive cost savings, and deliver better patient outcomes

Elevating brand outreach in the age of Covid

Are regulations hindering pharma innovations?

Commercial Channels